Surveillance of antimicrobial resistance in resource-constrained settings - experience from five pilot projects

Tropical Medicine and International Health

Volumn 16, Issue 3, 2011, Pages 368-374

  Holloway, Kathleen ^a   Mathai, Elizabeth ^b   Gray, Andy ^c  

^a WHO Regional Office for South East Asia ^*  (India)

^b Patient Safety Programme   (Switzerland)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Antimicrobial resistance; Community; Developing countries; Surveillance

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; NALIDIXIC ACID;

ANTIMICROBIAL ACTIVITY; COLIFORM BACTERIUM; COMMUNITY COMPOSITION; DEVELOPING WORLD; INHIBITOR; PUBLIC HEALTH; WORLD HEALTH ORGANIZATION;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM ISOLATE; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; INDIA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PILOT STUDY; SOUTH AFRICA; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; DEVELOPING COUNTRIES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HUMANS; INDIA; MEDICALLY UNDERSERVED AREA; MICROBIAL SENSITIVITY TESTS; PILOT PROJECTS; POPULATION SURVEILLANCE; SOUTH AFRICA; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; STREPTOCOCCUS PNEUMONIAE;

EID: 79951745508     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2010.02696.x     Document Type: Article

References (21)

1. Bartoloni A, Pallecchi L, Benedetti M et al. (2006a) Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia. Emerging Infectious Diseases 12, 907-913.
2. Bartoloni A, Benedetti M, Pallecchi L et al. (2006b) Evaluation of a rapid screening method for detection of antimicrobial resistance in the commensal microbiota of the gut. Transactions of the Royal Society of Tropical Medicine and Hygiene 100, 119-125.
3. Coombs G, Nimmo GR, Pearson JC, Christiansen K, Bell JM, Collignon PJ & McLaws M-L (2009) Prevalence of MRSA strains among Staphylococcus aureus isolated from outpatients, 2006. Communicable Diseases Intelligence 33, 10-20.
4. Holloway KA, Mathai E, Sorensen T et al. eds (2009) Community-Based Surveillance of Antimicrobial Use and Resistance in Resource-Constrained Settings. Report on five pilot projects, World Health Organization, Geneva.
5. Huang XQ, Xiao ZY, Deng L et al. (2006) [Surveillance of antimicrobial susceptibility of Streptococcus pneumoniae and Hemophilus influenzae isolated from children in Guangzhou area between 2003 and 2004]. Zhonghua Er Ke Za Zhi 44, 441-444.
6. de Kraker M & van de Sande-Bruinsma N (2007) Trends in antimicrobial resistance in Europe: update of EARSS results. Eurosurveillance Weekly 12, E070315.3.
7. Lester SC, del Pilar Pla M, Wang F, Perez Schael I, Jiang H & O'Brien TR (1990) The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China. New England Journal of Medicine 323, 285-289.
8. Melo-Cristino J, Santos L & Ramirez M (2000) The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004. Revista Portuguesa de Pneumologia 12, 9-30.
9. Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG & Fritsche TR (2007) Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagnostic Microbiology and Infectious Disease 57, 7-13.
10. Mölstad S, Erntell M, Hanberger H et al. (2008) Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. The Lancet Infectious Diseases 8, 125-132.
11. Murphy O, Murchan S, Whyte D et al. (2005) Impact of the European Antimicrobial Resistance Surveillance System on the development of a national programme to monitor resistance in Staphylococcus aureus and Streptococcus pneumoniae in Ireland, 1999-2003. European Journal of Clinical Microbiology and Infectious Diseases 24, 480-483.
12. National Committee Clinical Laboratory Standards (2002/2003) Performance Standards for Antimicrobial Disk Susceptibility Testing. Eighth Edition, Approved Standards, NCCLS document M2-A8 (2003) and Twelfth informational supplement, NCCLS document M100-S12 (2002), Wayne, PA, USA.
13. Niki Y, Hanaki H, Matsumoto T et al. (2009) Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2007: general view of the pathogens' antibacterial susceptibility. Journal of Infection and Chemotherapy 15, 156-167.
14. Nys S, Okeke IN, Kariuki S, Dinant GJ, Driessen C & Stobberingh EE et al. (2004) Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries. Journal of Antimicrobial Chemotherapy 54, 952-955.
15. Okeke I, Fayinka S & Lamikanra A (2000) Antibiotic resistance in Escherichia coli from Nigerian students, 1986 1998. Emerging Infectious Diseases 6: 393-396.
16. Sabuncu E, David J, Bernede-Bauduin C et al. (2009) Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Medicine 6, e1000084.
17. Saha SK, Naheed A, El Arifeen S et al. (2009) Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution. Clinical Infectious Diseases 48(Suppl. 2), S75-S81.
18. Sannes M, Kuskowski M & Johnson J (2004) Antimicrobial resistance of Escherichia coli strains isolated from urine of women with cystitis or pyelonephritis and feces of dogs and healthy humans. Journal of the American Veterinary Medical Association 225, 368-373.
19. Stelling JM, Travers K, Jones RN, Turner PJ, O'Brien TF & Levy SB (2005) Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs. Emerging Infectious Diseases 11, 873-882.
20. World Health Organization (2001) Global Strategy for Containment of Antimicrobial Resistance. World Health Organisation, Geneva.
21. World Health Assembly (2005) Improving the Containment of Antimicrobial Resistance, WHA58.27. World Health Organization, Geneva.